Page last updated: 2024-09-05

methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate and ovalbumin

methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate has been researched along with ovalbumin in 1 studies

Compound Research Comparison

Studies
(methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate)
Trials
(methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate)
Recent Studies (post-2010)
(methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate)
Studies
(ovalbumin)
Trials
(ovalbumin)
Recent Studies (post-2010) (ovalbumin)
160019,565635,664

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Piper, PJ; Yaacob, HB1

Other Studies

1 other study(ies) available for methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate and ovalbumin

ArticleYear
Inhibition of leukotriene release in anaphylactic guinea-pig hearts by a 5-lipoxygenase inhibitor, CGS 8515.
    British journal of pharmacology, 1988, Volume: 95, Issue:4

    Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Anaphylaxis; Animals; Guinea Pigs; Heart; In Vitro Techniques; Lipoxygenase Inhibitors; Male; Naphthoquinones; ortho-Aminobenzoates; Ovalbumin; Perfusion; Prostaglandin-Endoperoxide Synthases; Pyrazoles; SRS-A

1988